Treatment of viral infections
OwnerRobert H. Kellerinventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines. In preferred embodiments, the invention further comprises quercetin. The components combine and interact in a manner to effectively treat viral infections.
Claims24
A pharmaceutical composition, comprising the combination of at least one calcium channel blocker;
- and at least one quinoline or a derivative or intermediate thereof, or salts thereof, in therapeutically effective amounts and proportions to reduce viral activity in mammals.
The composition of claim 11 wherein the quinoline component comprises chloroquine or derivatives thereof.
A pharmaceutical composition comprising effective amounts of verapamil and chloroquine or pharmaceutically equivalent derivatives thereof to reduce viral activity in an infected mammal.
A method of reducing viral activity in an infected mammal, comprising administering to a mammal with a viral infection, a therapeutically effective amount of at least one Ca channel blocker and a quinoline or derivatives thereof, in sufficient amounts to treat and reduce viral activity in the mammal.
Dependencies are inferred from the claim text.